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HIGHLIGHTS
•  For setting the therapeutic goals for patients with Parkinson's disease (PD), 
rehabilitation specialist should confirm the disease diagnosis and progression of 
individual patients with PD.
•  It is recommended for clinicians to assess the motor (gait, mobility, or balance), cognition, 
speech and swallowing function in patients with PD and to include a barrier or facilitator 
(environmental or personal factors) for evaluating their function and outcomes of the 
interaction between health condition and those factors.
•  Assessment of functional status for rehabilitation in patients with PD is recommended at 
the time of diagnosis. Evaluation of function is recommended regularly every 3 to 6 months 
for patients who are receiving rehabilitation and every 6 to 12 months if not treated.
•  The assessments of gait and balance function in patients with PD should be done with 
the diagnosis of the disease, and periodic assessments as the disease progresses should 
be performed at least a 3-month interval. The assessments of gait and balance function in 
patients with PD are recommended using the Unified Parkinson's Disease Rating Scale and 
Berg Balance Scale near to the same time as possible during the follow-up evaluation.
•  To improve balance and gait in patients with PD, various rehabilitation approaches 
including aerobic exercise, balance exercise, aquatic exercise, dancing exercise, virtual 
reality, activity of daily living (ADL) training, Lee Silverman Voice Treatment (LSVT) BIG 
program, task-oriented occupational therapy, and self-exercise programs are needed.
•  Patients with PD should be evaluated regularly regarding their ADLs since the first visit 
of clinics especially when an evaluation of therapeutic effect or a decision of therapeutic 
strategies is required.
•  Occupational therapy is recommended for patients with PD who have limitations in ADLs. 
And treatment should be provided based on specific knowledge and understanding of PD 
with consideration of the individual needs and circumstances of the patient.
•  Patients with PD who are suspected of swallowing disorder or those with a high risk of 
swallowing disorder (excessive drooling, excessive weight loss, frequent aspiration) need 
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to perform a videofluoroscopic swallowing study or fiberoptic endoscopic evaluation of 
swallowing.
•  Patient and caregiver education about swallowing disorder should be provided at the 
early stage of PD. And compensatory approaches including chin tuck, external cues, and 
thickeners, and restorative approaches including LSVT and expiratory muscle strength 
training, can be considered for swallowing rehabilitation in patients with PD depending on 
the swallowing problems experienced by the patient.
•  Communication disorders in patients with PD may occur at an early stage and require 
a careful observation because they greatly affect the quality of life of patients. Although 
there are no validated assessment tools yet, with difficulty in adjusting the volume of voice, 
caregiver education and careful observation are needed.
•  Effective communication strategies should be developed and taught to patients and 
caregivers in the early stages of PD and speech and language therapy such as LSVT and 
compensation methods using instrumental aids should be considered according to the 
patient's communication ability.
https://doi.org/10.12786/bn.2020.13.e17
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Clinical consensus statements (CCSs) aim to improve care for patients with Parkinson's disease 
(PD) and reduce the variability of rehabilitation methods in clinical practice. A literature search 
was conducted to find available evidence on the rehabilitation of patients with PD and to 
determine the scope of CCSs. The selection of PD rehabilitation domains and key questions 
was done using the modified Delphi method in 43 expert panels. These panels achieved a 
consensus on 11 key questions regarding rehabilitation assessment and goal setting, gait and 
balance, activities of daily living, and swallowing and communication disorders. After the 
completion of an agreement procedure, 11 key consensus statements were developed by the 
consensus panel. These statements addressed the needs of rehabilitation as a continuum in 
patients with PD. They included the appropriate rehabilitation initiation time, assessment 
items, rehabilitation contents, and complication management. This agreement can be used 
by physiatrists, rehabilitation therapists, and other practitioners who take care of patients 
with PD. The consensus panel also highlighted areas where a consensus could not be reached. 
The development of more focused CCS or clinical practice guidelines that target specific 
rehabilitation approaches is considered the next needed step.
Keywords: Consensus; Parkinson's disease; Rehabilitation
INTRODUCTION
Parkinson's disease (PD) is the second most common progressive neurodegenerative 
disorder after Alzheimer's dementia. It causes various motor manifestations which make it 
difficult to perform the activities of daily living (ADLs). The need for PD rehabilitation has 
been emphasized as a social problem for the aging population. Recently, there has been an 
increase in the number of degenerative diseases that limit the performance of a patient's 
ADLs. An example of such diseases is PD.
There is evidence that a multidisciplinary approach for patients with PD leads to an increase 
in community health care and the patient's quality of life (QoL) [1,2]. This often involves 
education of the patient and his family, assessment of functions and complications, and 
rehabilitation therapy. There is a variation in the management of patients with PD among 
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primary, secondary, and tertiary hospitals. The same holds true for inpatient units and 
outpatient clinics. In order to improve the QoL for PD patients, it is necessary to prepare 
a medical environment where patients can receive a certain level of care at any medical 
institution. However, evidence-based recommendations from systematic reviews have been 
difficult to elicit because the randomized control trials conducted on the rehabilitation of 
Korean patients with PD have been minimal.
The clinical consensus statements (CCSs) can be defined as statements based on expert opinions 
and the best available research which seek to identify—using an explicit a priori methodology—a 
consensus between areas of agreement and disagreement. These, therefore, form a combined 
version of the narrative review [3]. The CCS is most applicable to situations where the evidence 
base is insufficient for a clinical practice guideline (CPG); however, significant changes in 
practice exist with opportunities for quality improvement [3]. Thus, the Korean Society for 
Neurorehabilitation (KSNR) launched a task force and consensus panel composed of experts 
on brain disorder rehabilitation to create a CCS for the rehabilitation of PD. This study aimed 
to develop a CCS that would improve and reduce the variability of rehabilitation approaches in 
Korean patients with PD. A modified Delphi method was used for the consensus development.
MATERIALS AND METHODS
The process of reaching a consensus was carried out according to the following procedure: 
formation of the expert panel, preliminary literature search, selection of key questions, 
and use of the modified Delphi method for agreement. The overview of the process used to 
develop the CCS is shown in Fig. 1.
1)  Expert panel: Initially, a task force (TF) consisting of 12 experts from the KSNR Commit-
tee of CPG launched the development of a CCS for the rehabilitation of patients with PD. 
The TF reviewed the purpose and scope of the CCS development process on the first con-
ference call. Forty-three experts were listed to be part of the CCS panel consisting of highly 
experienced specialists in the neurorehabilitation of brain disorders, including PD.
2)  Preliminary literature search: The initial literature search was conducted by the TF, 
in accordance with the scope and purpose of the CCS for PD. Each member of the TF 
researched published CPGs related to PD rehabilitation. These were then collectively 
reviewed by the TF for eligibility. As a result, eight guidelines met the scope of this CCS. 
These eight guidelines were reviewed by 2 members of the TF. The guideline results 
were shared and discussed in the second conference call.
3)  Selection of key questions: During the second conference call, the core committee 
selected 10 key questions based on Population, Intervention, Comparison, and Out-
come (PICO). From the key questions, a second literature search was performed using 
the databases of PubMed, EMBASE, and Cochrane Central. The literature search 
encompassed systematic reviews, meta-analyses, randomized control trials (RCTs), and 
observational studies. Only literature written in English were selected.
4)  Modified Delphi Method: This strategy was chosen as the agreement procedure for 
the key CCS questions. All the expert panels were asked to answer each key question. 
The responses were reviewed in a conference call. Thereafter, the key questions were 
refined. The final key questions were selected based on the average value of the panels' 
priorities and the weight of the areas agreed upon by the members of the conference.
5)  Statistical analysis: A descriptive analysis was used on each Delphi survey response, 
such as the mean value of priorities.
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As a result of 3 conferences, 10 key question major domains were selected. From these 10 
major domains, 5 were dropped during the first round of the Delphi survey. In succeeding 
conferences, 20 subdomain key questions and statements developed from the 5 remaining 
major domains were discussed. After the second round of Delphi surveys, 11 final key 
questions and statements for the CCS were formulated (Table 1).
Key questions and statements
Key question 1: How should the goals of rehabilitation therapy be set for patients with PD?
PD is the second most common neurodegenerative disease after Alzheimer's disease [4]. 
Most patients with PD are diagnosed when they are above 60 years old. The prevalence 
of PD increases with age: 1.4% and 4.3% over the ages of 60 and 85, respectively [5]. The 
diagnosis is primarily based on clinical criteria: the presence of bradykinesia and the 
progressive reduction of speed and amplitude for repetitive movements [6]. In addition, 
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Key statements achieving consensus: In setting the therapeutic goals of patients with 
PD, a rehabilitation specialist should confirm the diagnosis of each patient and monitor 
the progression of the disease.
Select expert panel • 43 panel members for KSNR PD writing groups• 12 panel members for TF
Conference call 1 • Facilitation introduction• Review purpose and develop scope (PICO)
Initial literature search • Domestic and international guidelines
Conference call 2 • Developing the major domain of key questions (n = 10)
Secondary literature search • Systematic review, meta-analysis, RCT, observational study
Conference call 3 • Refining the major domain of key questions (n = 10)
Modified Delphi survey 1 • 43 Expert panel• Priority for each major domain of key questions (n = 10)
Conference call 4 • Refining the major domain of key questions (n = 5)• Developing the subdomain of key questions and statements (n = 20)
Modified Delphi survey 2 • 43 Expert panel• Priority for each key questions and statements (n = 20)
Conference call 5 • Confirm key questions and statements (n = 11)
Fig. 1. Consensus development process using a modified Delphi method. 
KSNR, Korean Society for Neurorehabilitation; PD, Parkinson's disease; TF, task force; PICO, Population, 
Intervention, Comparison, and Outcome; RCT, randomized control trial.
rigidity, resting tremor, or postural instability need to be present. Additionally, the “red 
flags,” including a symmetrical start and the symptoms of falling within the first year and no 
response to levodopa in the early stages, need to be absent. The symptoms of PD and atypical 
parkinsonism can show some (10%–20%) overlap [7]. Postural and axial symptoms (such as 
gait difficulty) express more rapidly than other motor symptoms; these appear to be the best 
indices of disease progression [8]. However, most patients with PD also have disturbances in 
non-motor function domains. In addition, individual variations in the disease progression 
are large. In general, women can reach a Hoehn and Yahr scale (HY) of 3 (Table 2) [9] and 
experience motor complications earlier than men. These motor complications include motor 
fluctuations, dyskinesia, and gait freezing [10]. Individuals with a longer duration of disease 
and treatment and those with a younger age at onset usually have higher rates of treatment-
related motor complications than other subtypes (Table 3) [11,12].
To monitor the progression of PD, physicians often use the Unified Parkinson's Disease 
Rating Scale (UPDRS) or the newer Movement Disorder Society (MDS)-UPDRS revised by 
expert members of the MDS [13]. This tool provides a composite score for disease severity, 
including mental and motor function, ADL, and complications [13]. To set the goals for 
patients with PD, the rehabilitation specialist should confirm the diagnosis and monitor 
the disease progression of patients with PD individually. Before setting the individual goal, 
knowing where the patient is standing during his journey on this famous degenerative 
disease might be essential to the rehabilitation team. According to the European guidelines 
of physical therapy for patients with PD, the ultimate goal is to optimize activities, 
participation, and QoL. This is done by considering the patient's functioning, personal 
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Table 1. Major domains and subdomains used in Delphi surveys
Major domain Sub-domain
Evaluation and Goal setting Evaluation
Goal setting
Upper extremity function Evaluation
Treatment
Balance and Gait Evaluation
Treatment














Table 2. Hoehn & Yahr staging scale
Stage Description Phase
1 Unilateral involvement; minimal or no functional disability Early
2 Bilateral or midline involvement; no impairment of balance Mid
3 Impaired postural reflexes; mild to moderate activity limitations Mid
4 Severe activity limitations, but able to walk or stand Mid
5 Confinement to bed or wheelchair Late
characteristics, and environmental factors [14]. Treatment strategies for patients with PD 
should focus on symptom control and compensation. Symptomatic treatments include 
a variety of drugs and rehabilitation approaches. Since patients with PD have a complex 
nature of symptoms, interdisciplinary health care professionals can be involved in the care 
of these patients [1,15]. Current medical management only has a partial effect in controlling 
the functional disturbances in PD. Motor and non-motor impairments occurring late in the 
course of the condition include gait freezing, imbalance, and cognitive impairments. In fact, 
medications may even worsen these functional disturbances. Consequently, even patients 
with optimal medical management can feel various problems in daily functioning. Therefore, 
a wide variety of healthcare professionals may be required. Furthermore, communication 
between the patient and healthcare professionals is very important [16].
Key question 2: What should be assessed for rehabilitation in patients with PD?
The deterioration of symptoms in PD is manifested by the course of the disease but may 
also be due to medications or inactivity. These PD complexities go hand in hand with the 
rate of the disease progression and daily functioning. Therefore, the evaluation of patients 
with PD is important. It is necessary to undertake the challenge of describing the patient's 
functioning as to proper timing [13,14].
In clinical practice, the HY, UPDRS, and MDS-UPDRS are useful measurements to classify 
the disease severity and comprehend the overall function in patients with PD. Based on the 
HY stages, the early phase (HY 1 to 2) has little to no limitations. The goal of the therapeutic 
intervention is to engage in regular exercise and maintain a level of physical fitness. 
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Key statements achieving consensus: It is recommended for clinicians to assess the 
motor manifestations (gait, mobility, or balance), cognition, speech, and swallowing 
function in patients with PD. The inclusion of a barrier or facilitator (environmental 
or personal factors) for evaluating a patient’s level of functioning is warranted. The 
outcomes of the interaction between environmental or personal factors and the health 
condition must be evaluated.
Table 3. Subtypes of Parkinson's disease
Classification Subtypes Associations clinical features
Age Earlier onset (< 55 years) type - Late onset of falls
- Late onset of cognitive decline
- Early onset of freezing gait
- Higher risk for anxiety
- Shorter time to dyskinesia
- Longer time to HY 3
Clinical phenotype TD type - Poorer response to medication
- Slower disease progression
- Lower risk of mood impairments
- Lower risk for dementia compared to PIGD type
- Longer time to HY 3 compared to PIGD type
PIGD type - Predominant gait and posture impairments
- Higher prevalence and severity of depression
- Higher prevalence of dementia
Non-motor PD-MCI type - Only mild cognitive impairment
Dementia (PDD) type - Only severe cognitive impairment
HY, Hoehn and Yahr scale; TD, tremor dominant; PIGD, postural imbalance and gait disorder; PD, Parkinson's 
disease; MCI, mild cognitive impairment; PDD, Parkinson's disease with dementia.
Prevention of inactivity and improvement of physical capacity should be the main goals of 
intervention in this phase. Deconditioned patients with a reduced self-awareness of deficits 
may need to administer a self-management program [15]. In the mid-phase (HY 2 to 4), 
the treatment goal is to preserve activities. Hence, exercise therapy is focused on the motor 
functions including balance, posture, or gait. In the late phase (HY 5), it is important to 
educate the caregivers to prevent complications such as pressure ulcers and joint contractures 
[15]. However, specific attention to non-motor symptoms should also be given because these 
can manifest regardless of the disease severity [16].
Tools to evaluate the functioning of patients with PD include patient- or caregiver-reported 
questionnaires and performance-based assessments. Questionnaires are more practical 
for clinical applications; however, limited comparative data are available [17]. Performance 
assessments evaluate the patient's function objectively; however, these may be more time-
consuming [17]. Therefore, it is recommended that clinicians select the most appropriate 
measurement for specific therapeutic goals [13].
The aim of assessment for rehabilitation is based on the daily functioning of patients. For 
this, it is necessary to include a barrier or facilitator (environmental or personal factors) 
which would evaluate the outcomes of the interaction between the patient's function, health 
conditions, and environmental or personal factors [13,14]. It is important to figure out the 
actual performance of a person in executing tasks in his or her current environment. This 
may be during history taking and physical examination, as well as during communication 
with other health professionals [13].
The areas of motor function addressed in PD patients are mobility, balance, fall, and gait 
freezing. Measurement scales that fulfill the recommended criteria of specific parameters are 
as follows: gait (gait velocity, gait distance, Freezing of Gait questionnaire); mobility (Timed 
Up and Go test, Parkinson's Activity Scale, 5 times sit to stand); balance (fall frequency, Berg 
Balance Scale, Dynamic Gait Index, Mini-Balance Evaluation System Test); and, fall efficacy 
(Fall Efficacy Scale, Activities Balance Confidence scale). The patient's physical capacity 
may be assessed through the routine physical activity and ADL. Furthermore, instrumental 
ADL (Functional Independence Measure, Assessment of Motor and Process Skills, Canadian 
Occupational Performance Measure [COPM]) can be evaluated with questionnaires or 
performance assessments.
The areas of non-motor functioning addressed in patients with PD are cognitive impairment 
(mild cognitive impairment, dementia), mood disorders (anxiety, depression), swallowing 
disorders (drooling, swallowing difficulty), impulsive control disorders, sleep disorders, 
autonomic function disorders (orthostatic hypotension, voiding disorder, erectile 
dysfunction), hallucinations, delusions, pain, and fatigue. Cognition, speech, and the 
swallowing function are related to rehabilitation interventions for non-motor symptoms. 
Evaluation of the cognitive function in PD is not just for the diagnosis of mild cognitive 
impairment or dementia. It is also geared toward effective motor learning in rehabilitation 
strategies. Cognitive status is one of the main determinants of a rehabilitation outcome. 
Feedback and motivation may be helpful in achieving cognitive engagement [18]. The speech 
problem generally originates from the weakness of the muscles related to articulation. The 
following speech areas need to be evaluated: loudness, articulation, fluency, resonance, 
and prosody. The standard evaluation of the swallowing function is a videofluoroscopic 
swallowing study (VFSS). It aids in assessing the swallowing function with clinical symptoms 
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such as drooling, choking, cough, nutrition status, feeding posture, and respiratory function 
[19,20]. In addition, certain factors can influence the rehabilitation goal setting. The overall 
QoL (PD-specific quality of life 39, EuroQol-5 Dimension), dystonia, dyskinesia, comorbidity, 
and the environment of a PD patient need to be assessed [17].
Most clinical assessments are for overall functioning. No instrument comprehensively 
evaluates PD specifically. Therefore, we suggest the development of a Parkinson's-specific, 
easily administered, and comprehensive assessment tool for rehabilitation intervention.
Key question 3: When and how often should patients with PD be assessed for rehabilitation?
The initial assessment for rehabilitation in patients with PD should be done at the time of 
diagnosis. Studies have shown that, compared to general populations of the same age, the 
activity of patients with PD is significantly lower at the time of diagnosis. That is, functional 
activity is already impaired at the time of diagnosis [17]. Therefore, patients diagnosed with 
PD should be considered for referral to a specialist to ensure regular assessment and training 
of motor and non-motor symptoms. The rehabilitation should be decided accordingly. 
Experts in PD have postulated that early-stage rehabilitation could slow the progression of PD 
symptoms [18]. In particular, referral to rehabilitation specialists for regular evaluation and 
treatment should be done to address balance and motor problems, independency of ADL, 
and swallowing and communication function. Although the consensus of the expert group 
has not yet agreed on an evaluation interval, the interval of 6-12 months is recommended for 
assessing the functional status of patients with PD [19]. For patients ongoing rehabilitation, 
the recommended treatment is at least 4 weeks for gait therapy, 8 weeks for balanced 
training, and 12 weeks for aerobic exercise and strength training [20].
Key question 4: When and how do you assess the gait and balance functions in patients with PD?
The management of patients with PD has traditionally centered on pharmacologic options 
viewed as the gold standard treatments [21]. Despite optimal pharmacologic treatments, 
the gait and balance functions have become more severe. The risk of fall has consistently 
increased parallel to the progression of PD. The increased risk of fall can cause fall-related 
injuries such as traumatic brain injuries and fractures. Consequently, the overall survival 
of those who experience falls can be reduced [22]. Therefore, proper rehabilitation—in 
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Key statements achieving consensus: Assessment of the functional status for the 
rehabilitation of patients with PD at the time of diagnosis is recommended. Evaluations 
are recommended to be done regularly, every 3 to 6 months, for patients who are 
receiving rehabilitation. If untreated, functional evaluations should be carried out every 
6 to 12 months.
Key statements achieving consensus: The assessments of gait and balance functions in 
patients with PD should be done upon diagnosis of the disease. Periodic assessments 
should be performed with at least a 3-month interval as the disease progresses. The 
assessments of gait and balance functions in patients with PD using the UPDRS and 
Berg Balance Scale are recommended to be done near the same time as possible during 
follow-up evaluations.
conjunction with pharmacological treatment—is highly encouraged to improve and 
maintain the gait and balance functions [14,18,20,23]. In most studies about the effects of 
rehabilitation on gait and balance in PD patients, participants had mild to moderate severity 
with an HY of 2 to 3 [20,24]. There were few reports on PD patients with an HY of 4 to 5 gait 
and balance functions. However, according to the European guideline of physical therapy for 
patients with PD and the National Institute for Health and Care Excellence (NICE) guidelines 
of PD, the rehabilitation for gait and balance is recommended in all patients with PD, 
regardless of the disease severity. This is because the rehabilitation, which includes education 
for patients and caregivers, may be effective in improving the gait and balance functions 
[14,18]. In addition, comprehensive rehabilitation is recommended to maintain gait and 
balance in patients with severe PD. Therefore, the assessment of gait and balance function 
in patients with PD should be done upon the diagnosis of the disease. Periodic evaluations 
should be conducted as the disease progresses. Appropriate rehabilitation, including 
education, should be performed even if the gait and balance functions are not deteriorated. 
Because PD is a slowly progressive neurodegenerative disorder, periodic assessments of gait 
and balance function are essential. However, a clear recommended assessment schedule for 
gait and balance is not well known. Most studies on the effects of rehabilitation on gait and 
balance in patients with PD have reported that treatment effects continued for 3 to 12 months 
after rehabilitation [20]. In addition, a study of community-based dancing performed on 
patients with PD showed that the rate of participation decreased sharply at the 3-month time 
point [25]. Most studies on the effects of rehabilitation in patients with PD were based on 
a 3-month time point assessment of functional changes [14]. Based on the results of these 
studies, a follow-up evaluation with at least a 3-month interval is thought to be necessary to 
maintain or improve the compliance of rehabilitation in PD patients.
The gait and balance assessment tools recommended are UPDRS Parts III and IV (severity 
of PD), the 6-minute walk test, the 2-minute step test, and VO2max for cardiopulmonary 
function. Balance Evaluation Systems Test (BESTest), mini-BESTest, Berg Balance Scale, and 
Five Times Sit-to-Stand Test were performed objectively to assess the balance function. The 
surveys of the Activities Balance Confidence Scale and the Fall Efficacy Scale can also be used 
to assess balance. For the gait function, a 10-meter walk test can be performed as an objective 
assessment tool. The Freezing of Gait Questionnaire can be used as a survey. In addition, the 
Timed-up and-go Test, Short Physical Performance Battery, Modified Physical Performance 
Test, and Contiguous scale-physical functional performance have been used to assess 
functional mobility [14,18,20]. It is recommended that these various measures be structurally 
divided into body function, activities, and participation according to the International 
Classification of Functioning, Disability, and Health (ICF) [14]. Although several assessment 
tools have been proposed, UPDRS and Berg Balance Scale have been proven clinically 
meaningful among the indicators of gait and balance function in patients with PD [18]. Most 
of the other indicators were not clear enough in establishing a minimal clinically important 
difference. It is difficult to expect a clinically meaningful change in the evaluation index after 
rehabilitation [18]. Therefore, it is recommended that UPDRS and Berg Balance Scale should 
be used as the primary assessment tools for periodic evaluations of gait and balance function in 
patients with PD. Other assessment tools can be used for additional purposes [18]. In patients 
with PD, gait and balance functions can vary greatly during different days. The measurements 
of these functions should be assessed during the patient's optimal functioning state and not 
during off states when the patient is most limited [14]. Therefore, the time of assessment 
should be recorded in relation to the medication state and time of day. Repeat assessments 
should be made as near as possible to the same time during follow-up evaluations [14].
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Key question 5: How should rehabilitation in patients with PD be done to improve balance 
and gait?
Gait difficulty and imbalance are frequently encountered in patients with PD. These may 
induce fractures by falls that have been reported in approximately 68% of patients with 
PD annually [26]. Moreover, gait difficulty and imbalance would gradually progress with 
disease progression. This would be reflected by the severity of PD [27]. In key question 4, the 
evaluation of gait and balance were introduced. In key question 5, the rehabilitation types for 
gait and balance would be described.
The gait and balance problems in PD have shown various phenotypes: postural sway, short 
stride, and gait freezing (typically start and turning hesitations) [28,29]. Rehabilitation 
approaches consist of compensatory methods such as providing external or internal cues 
and acquiring new gait patterns in patients with early-stage PD [30]. In the late stage of PD, 
the rehabilitation should provide more personalized and intensive programs. The general 
principles of rehabilitation in PD are: first, make the therapeutic goal; second, repeat the task 
or exercise until maximum effects are achieved in the results [31]. Balance training improved 
the balance, trunk control, and gait stability more effectively than resistance exercises [32]. 
For improvement of balance, aquatic exercise, and virtual reality have also been beneficial 
[33-35]. Several therapeutic strategies such as dance therapy, treadmill training, and cued 
exercise training have proven useful for improving balance and restoring gait [32,33,36-39]. 
The partial weight-bearing treadmill was also effective in improving the gait of patients with 
PD [40]. In a systematic review for the effects of occupational therapy on balance, several 
forms of occupational therapy—including basic daily life training—may help to promote 
balance and thereby, maintain maximum independence of daily life, work, and leisure 
activities [41,42]. Among these various treatment strategies, no strategy has been proven 
to be more superior than others. The combination of various strategies is recommended to 
be an effective treatment of PD [14,24,43]. These rehabilitation programs should be useful 
for controlling bradykinesia, improving the velocity of gait, preventing falls, and inducing 
independency of ADLs [23,43].
The LSVT BIG program has been used as a self-exercise program for improving balance and 
walking. After introducing LVST LOUD for improving speech and language, LVST BIG was 
developed to improve motor function in patients with PD [44]. Since the LVST BIG program 
has a bigger amplitude of voluntary motion, it may improve hypokinesia, velocity, and fine-
tuning of motions [44] It has been used for rehabilitation and self-exercise programs [44,45]. 
After the 16-week LSVT BIG program, improvements in the walking speed and gains of 
UPDRS scores were reported [46].
Several kinds of research on self-exercise programs (i.e., dancing) have investigated for 
improvements in motor function, balance, and QoL [39]. The several self-exercise programs 
shall be introduced in the forthcoming clinical guidelines for rehabilitation of PD.
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Key statements achieving consensus: To improve balance and gait in patients with PD, 
various rehabilitation approaches are needed. These include aerobic exercise, balance 
exercises, aquatic exercise, dancing exercise, virtual reality, ADL training, Lee Silverman 
Voice Treatment (LSVT) BIG program, task-oriented occupational therapy, and self-
exercise programs.
Considering these recent researches and clinical guidelines, it is recommended that patients 
with PD be treated with various rehabilitation programs. These therapies consist of self- exercise, 
occupational therapy, or other various programs to prevent complications such as falls, balance 
problems, and gait difficulties [28,41,45,47]. The rehabilitation programs would be considered in 
the early stages of PD. The rehabilitative interventions should be approached by various methods 
such as aerobic exercise, balance training, aquatic exercise, therapeutic dance, virtual reality, 
training for the activities of daily living, and the LSVT BIG program [24,31,33,37,45].
Key question 6: When do you evaluate ADLs in patients with PD?
PD causes a variety of motor and non-motor symptoms and impairs independence in ADLs. A 
previous study reported the ADLs of patients with PD were impaired significantly even before 
the diagnosis [48]. Therefore, every subject with a suspicion of PD needs to be evaluated 
regarding the ADLs. ADL evaluation at the time of diagnosis enables an individualized 
rehabilitation from an early phase of the disease. Since the performance of ADLs is a reliable 
marker of disease progression, as well as an important factor of QoL in patients with PD, a 
follow-up ADL evaluation is needed to assess the disease progression and predict QoL.
Several longitudinal studies have shown that ADL parameters, such as MDS-UPDRS part 
II, change significantly annually. It is hard to provide a specific guideline regarding the 
evaluation interval, but it can be inferred that ADL evaluation should be done annually with the 
consideration of longitudinal study results. However, PD has heterogeneous clinical features. The 
disease progression and concurrent ADL performance can be affected by age at onset, disease 
duration, and comorbidities. Specifically, we may need to evaluate ADL performance more 
frequently in older subjects and subjects with the postural imbalance and gait difficulty (PIGD) 
type. They tend to frequently have a more rapid disease progression and functional decline [47].
The European guideline of physical therapy for patients with PD suggested evaluating patients 
based on appropriate assessment tools for evaluating the effect of rehabilitation therapy, 
both during and at the end of therapy [14]. Evaluation is required to decide on continuation, 
modification, or termination of therapy. It is also necessary to motivate patients to adhere to 
therapy and enable more effective communication within medical teams.
ADL evaluation is also needed in case a subject faces significant changes in therapeutic plans 
such as new medications, non-pharmacological (e.g., rehabilitation), or surgical (e.g., deep 
brain stimulation) treatments. Evaluation of the efficacy of treatment and application of 
appropriate therapies should be carried out before and during therapy.
Key question 7: How do you rehabilitate patients with PD to improve their ADLs?
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Key statements achieving consensus: With regards to their ADLs, patients with PD 
should be evaluated regularly—starting from the first clinic visit—especially when an 
evaluation of a therapeutic effect is required or therapeutic strategies are decided.
Key statements achieving consensus: Occupational therapy is recommended for patients 
with PD who have limitations in their ADLs. Treatment should be provided based on 
specific knowledge and understanding of PD, with consideration of the individual needs 
and circumstances of the patient.
Regarding the ADLs of patients with PD, the NICE guidelines of PD [18] recommended 
offering disease-specific occupational therapies for these patients with difficulties. The 
Canadian guidelines on PD [23] suggested that occupational therapy should be available 
for patients with PD, with particular consideration on the improvement and maintenance 
of work and family roles, home care and leisure activities, transfers and mobility, personal 
self-care activities such as eating, drinking, washing, and dressing, and environmental 
issues in improving the safety and motor functions. Additionally, cognitive assessments 
and appropriate interventions should be undertaken. The Netherlands guidelines in PD 
rehabilitation [42] proposed that occupational therapy was indicated when the patient 
with PD experienced activity limitations or participation problems in ADLs, work, and 
leisure. Occupational therapy was also advised when the caregiver experienced problems 
in supervising or supporting the patient's ADLs and when the health care provider had 
questions regarding the patient's safety and self-reliance in carrying out ADLs.
Sturkenboom et al. [49] conducted a multicenter, randomized, controlled clinical trial that 
evaluated the efficacy of occupational therapy in patients with PD. One-hundred-ninety-one 
patients who felt they had difficulties in performing meaningful daily activities while living 
in their homes were enrolled. One hundred twenty-four participants in the experimental 
group received 10 weeks of occupational therapy, while 67 participants in the control group 
received usual care without occupational therapy. The experimental group showed significant 
improvements in self-perceived performance and satisfaction measured by the COPM 
at 3- and 6-months follow-up. In this study, occupational therapy was performed at the 
participants’ home. All occupational therapists who provided treatment were experienced 
therapists who received separate training before beginning the intervention.
The following points should be considered when providing occupational therapy for patients 
with PD [42]: 1) Emphasize and encourage the importance of self-management in order to 
improve ADLs performance; 2) Adjust the daily structure and activities to optimize patient 
engagement and satisfaction; 3) Help reduce stress and time pressure in performing ADLs; 
4) Practice arm or hand motor skills for meaningful activities within the patient's ability; 5) 
Train consciously focusing attention on the occupational performance; 6) Utilize cognitive 
movement strategies that train the step-by-step occupational performance when performing 
complex tasks; 7) Minimize dual tasks; 8) Use cues to improve movement and occupational 
performance; 9) Modify the physical environment to promote the safety, effectiveness, and 
efficiency of performing activities; 10) Advise and supervise caregivers (Table 4). The purpose 
of rehabilitation is to help patients with PD continue participating in the roles and activities 
that are meaningful to them. In providing rehabilitation for patients with PD, not only the 
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Table 4. Occupational therapy interventions for patients with PD
No. Terms
1 Encouraging self-management
2 Optimizing daily structure and activities
3 Dealing with stress and time pressure
4 Practicing arm or hand motor skills
5 Occupational performance with focused attention
6 Applying cognitive movement strategies
7 Minimizing dual tasks
8 Using cues
9 Optimizing the physical environment
10 Advising and supervising caregivers
Recommendations from the Netherlands guidelines in PD rehabilitation [42].
PD, Parkinson's disease.
patient's basic ADLs, but also the vocational and leisure activities should be considered. 
Education and support for caregivers, as well as modification and improvement of the 
physical environment, should be included [50].
Key question 8: When and how should the swallowing function assessment be conducted 
in patients with PD?
Swallowing disorders are very well-known symptoms of PD in almost every terminal period. 
These can have significant impacts on the QoL and increase the death rate; however, the 
diagnosis or importance of swallowing problems is undervalued [51]. Swallowing disorders 
are also highly associated with complications in the respiratory system. These include 
aspiration pneumonia, dehydration, malnutrition, and long-term prognosis for PD [51]. 
Therefore, it is very important to prevent such complications by assessing if the signs of 
swallowing disorders are present prior to providing the proper PD treatment.
In the Canadian guidelines on PD [23], it is recommended that swallowing disorders as 
symptoms of autonomic nervous system abnormalities in patients with PD be evaluated 
and properly treated. If excessive drooling or excessive weight loss are noticeable, in case 
of aspiration pneumonia, an if aspiration symptoms occur more than once a week, it is 
recommended that assessment for swallowing disorders be conducted using such the VFSS 
or FEES. In patients with PD, the problem of gastrointestinal movements in the esophageal 
and oropharyngeal phases can be concurrent. It is, thus, recommended to consult 
gastrointestinal specialists in cases of suspected gastrointestinal movement disorders such as 
gastroesophageal reflux disease [23].
Two screening tools specific for PD—the swallowing disturbance questionnaire (SDQ) the 
Munich Dysphagia Test-Parkinson's disease (MDT-PD)—have been developed [52,53]. These 
screening tools can provide information on the need for further evaluation using equipment. 
A patient's state of consciousness and oropharyngeal function may be evaluated. The 
bedside examination using a water swallowing test can help assess the swallowing difficulty 
of patients with PD. The direct swallowing test, especially the 3oz water swallowing test, 
determines swallowing disorders associated with airway aspiration. Both the sensitivity and 
specificity of this test have been found to be high [54].
Standard tests for swallowing disorders which use instruments or equipment such as VFSS 
and FEES provide biomechanical information not found in screening tests. These evaluate for 
silent aspiration and are useful in assessing swallowing disorders caused by PD [55,56]. The 
endoscopic swallowing test specialized for PD (PARK-FEES) has been developed and verified 
to be of high inter-rater reliability. Upon comparing the incidence of aspiration pneumonia 
using the VFSS and FEES, no meaningful difference was reported between the two tests. 
These were, in fact, complementary to each other. Either of these tests can be selected, 
depending on the patient's condition or clinical situation [51].
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Key statements achieving consensus: Patients with PD who are suspected of swallowing 
disorders or those with a high risk of swallowing disorders (excessive drooling, excessive 
weight loss, or frequent aspiration) need to perform a VFSS or a fiberoptic endoscopic 
evaluation of swallowing (FEES).
Regarding the problems of esophageal and pharyngeal associations, these can be assessed 
by a high-resolution manometry test. This test can also be useful for assessing swallowing 
disorders in patients with PD [57,58].
Key question 9: When and how should the rehabilitation of swallowing disorders be  
performed in patients with PD?
Swallowing disorder is a common problem in patients with PD. The prevalence of a 
swallowing disorder was reported to be 16%–55% on subjective outcomes and 72%–87% 
on objective measurements [59]. Swallowing disorders may cause nutritional deficiency, 
dehydration, aspiration pneumonia, and asphyxia. Proper management of swallowing 
disorders is an important issue because pneumonia is the leading cause of hospital 
admission and death in patients with PD [60-62]. In this statement, the recommendations 
for the management of swallowing disorders in patients with PD were based on the NICE 
guidelines of PD [18], the Netherlands guidelines for speech and language therapy (SLT) in 
PD [63], and the results of some reported clinical trials.
Although there is no clear evidence when to perform rehabilitation of swallowing disorders 
in PD, it is recommended to consider assessment, education, and advice for swallowing in 
the early stages of PD. Also, offering proper treatment for patients who are experiencing 
problems with swallowing is deemed necessary [18]. Regarding the education for swallowing, 
it is recommended that physiatrists explain the normal process of chewing and swallowing to 
patients and caregivers and point out any errors in the present management. To reduce choking, 
it is recommended to educate patients on safe swallowing with attention and awareness. Chin 
tuck, smaller volumes, and thicker consistencies could be attempted for patients who easily 
choke on fluids. Activation exercises of the head-neck region prior to a meal, performing the 
swallowing process in conscious steps, and using specific cues are helpful for lengthy chewing. 
If these are not effective, slow initiation of swallowing and simpler food consistencies can 
be considered. For reducing pharyngeal residues after swallowing, effortful swallowing can 
be tried. If this proves to be difficult in improving residues, easier food consistencies can be 
considered. For patients who suffer from drooling, it is recommended to analyze the treatable 
causes and instruct the patients on proper strategies such as closing the mouth, adequate 
swallowing, and proper head and body posturing. It is advisable to actively involve the caregivers 
in the treatment of swallowing disorders, especially when the patient is dependent on external 
cues and movement strategies [63].
Although the rehabilitation of swallowing disorder in PD has been performed conventionally 
based on the abnormal findings confirmed by objective tests such as VFSS, there is a lack 
of evidence on the efficacy of these rehabilitations. LSVT is widely used for vocalization 
and swallowing improvements and in patients with hypokinetic swallowing disorders 
[63]; however, its efficacy has only been reported in a few small clinical studies [64,65]. 
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Key statements achieving consensus: Patient and caregiver education about swallowing 
disorders should be provided at the early stages of PD. Compensatory approaches 
including chin tuck, external cues, and thickeners should be considered. Restorative 
approaches including LSVT and expiratory muscle strength training should also be done 
for the swallowing rehabilitation of patients with PD. The approach would depend on the 
swallowing problems experienced by the patient.
Neuromuscular electrical stimulation using surface electrodes have been reported to have 
no additional effect on conventional swallowing therapy in patients with PD in terms of 
both the motor and sensory threshold stimulations [66,67]. The expiratory muscle strength 
training (EMST) which uses a device capable of controlling the target expiratory pressure of 
patients has been reported to reduce aspiration in patients with PD [68]. Therefore, EMST 
is a recommended swallowing therapy in PD [18]. Video-assisted swallowing therapy using 
visual feedbacks of the swallowing process has been reported to have additional effects on 
the conventional swallowing therapy in PD [69].
Key question 10: When and how should assessments be made for communication disorders 
in patients with PD?
Approximately 80%–90% of patients with PD have a voice change, while 45%–50% have 
changes in pronunciation [70,71]. Recent studies have shown that, compared with their 
spouses, cognitive impairments were observed in patients with PD who had difficulty 
communicating. However, no dementia symptoms were noted [72]. In the early stages of PD, 
language and cognitive changes occur. Therefore, it is important to receive an immediate 
evaluation if there is a suspicion since this can greatly affect the patient' QoL [2]. Different 
reactions and difficulties in the usual daily function or simple participation in social activities 
should not be overlooked.
To date, there have not been any validated methods for assessing communication disorders in 
PD. No communication disorder assessment tools for patients with PD have been developed. 
However, the first change observed in patients with PD is the difficulty in adjusting the voice 
volume [63].
The assessment of communication disorders is done by the Nijmegen Dysarthria Scale 
(NDS). It is rated at a 0–5 point system and is largely divided into two areas: dysarthria 
severity and level of communicative effectiveness [73,74]. In addition, additional 
communication evaluation factors such as intonation and accent, automatic speech tasks, 
maximum speaking time, and vocal range are considered [75,76]. Recordings of patient daily 
life conversations or video footage can also be helpful in the evaluation. It is necessary to 
educate the patient's caregivers to perform them whenever necessary.
Key question 11: When and how do you provide rehabilitation for the communication  
function in patients with PD?
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Key statements achieving consensus: Communication disorders in patients with PD may 
occur at an early stage and require a careful observation because these greatly affect the 
patient’s QoL. Although there are no validated assessment tools yet, for difficulties in 
adjusting the voice volume, caregiver education and careful observation are needed.
Key statements achieving consensus: Effective communication strategies should be 
developed and taught to patients and caregivers in the early stages of PD. SLT such 
as LSVT and compensation methods using instrumental aids should be considered 
according to the patient’s communication ability.
Speech or voice disorders in patients with PD are reported to be 70%–100%. However, a 2005 
study in the United States reported that only 3%–4% of patients with PD received SLT [77]. 
Contrary to this, the UK Parkinson's Disease Society published in 2008 that 34% of all patients 
with PD received SLT [78]. Recommendations for the rehabilitation of communication in 
patients with PD could be referred to the Canadian guidelines on PD [23], the NICE guidelines 
of PD [18], the Netherlands guidelines for SLT in PD [63], Spanish Clinical Practice Guideline 
for the management of patients with PD [79], and the results of recent systematic reviews and 
meta-analysis studies. Most guidelines recommend strategies for effective communication and 
SLT for patients with PD [18,23,63,79]. Although there is no clear evidence when rehabilitation 
of communication disorders should be initiated in patients with PD, it is suggested to 
consider assessment, education, and advice in the early stages of PD. Further, it is important 
to offer appropriate SLT for patients with PD who have communication problems [18]. In the 
Netherlands guidelines for SLT in PD, it is recommended that intensive SLT be applied to PD 
with hypokinetic dysarthria if the voice quality (loudness, clarity, and pitch) can be sufficiently 
stimulated, if the patient has enough motivation, and if the patient's attention and cognitive 
functions are sufficient to learn a new technique. The intensive SLT therapy should be done 
for at least 4 weeks, with 30 minutes per session, and more than thrice weekly. If the intensive 
therapy is not available, it is recommended to treat patients with less intensity and educated their 
caregivers [63]. Rehabilitation for the communication of patients with PD can be divided into the 
SLT—which directly improves the speech ability—and compensation methods. LSVT is the most 
widely used SLT and is recommended as a major program for patients with PD [18,23,63,79]. 
The LSVT has been shown to be effective in patients with PD in randomized controlled trials 
(RCTs) [80,81] and has been reported to have significant effects on the loudness of speech in a 
recent meta-analysis [82]. However, according to Cochrane reviews in 2012, there is insufficient 
evidence to conclusively support the efficacy of SLT versus placebo (or no intervention) in PD 
[83]. A comparative review of SLT techniques reported insufficient evidence on the efficacy of 
any form of SLT over another to treat speech problems in patients with PD [84]. However, it 
is unsafe to draw firm conclusions regarding the efficacy of SLT due to the lack of studies and 
large-scale RCTs [83,84]. The compensation methods for communication are as follows: using 
instrumental aids such as a pacing board, a metronome, and a portable amplification system. 
It is recommended that compensation methods be considered as communication strategies for 
patients with PD if the SLT is insufficient in helping to regain an acceptable communication or if 
the communication problems are severe [18,23,63,79].
DISCUSSION
The importance of rehabilitating degenerative brain disorders like PD is increasing. However, 
the evidence of rehabilitation is still lacking and large discrepancies of rehabilitation settings 
exist in clinical practice. These CCS were conducted to provide current available evidence on the 
rehabilitation of patients with PD and to reduce the variability in clinical practice by providing 
agreement statements after the completion of the modified Delphi method in 43 expert panels. 
Finally, consensus was achieved in 11 key questions and statements provided in the CCS.
At the beginning of developing the CCS process, 10 domains of common issues in PD were 
selected as major categories for voting: rehabilitation evaluation and goal setting, upper 
extremity exercise, balance and gait, ADLs, swallowing disorders, communication disorders, 
musculoskeletal problems, depression, cognitive dysfunctions, and neuromodulation 
therapy. In the first round of the Delphi survey, the expert panels responded with a 
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prioritization in the following order, from greatest to least: rehabilitation evaluation and 
goal setting, balance and gait, ADLs, swallowing disorders, communication disorders, 
cognitive dysfunction, upper extremity exercise, musculoskeletal problems, depression, 
and neuromodulation therapy. The upper extremity exercise domain was excluded because 
of agreement on low priorities. The panels pointed out that this was problematic only for 
patients with very advanced conditions. Furthermore, the panel gave low priorities for the 
depression and neuromodulation therapy domains because of the incongruence of the 
CCS scope and lack of well-designed researches and clinical trials on these topics. Finally, 
six domains of high priorities and 11 key questions were selected for the modified Delphi 
method. The consensus statements were listed together with explanations on currently 
available evidence in literature. This CCS may help to share current knowledge on the 
rehabilitation of PD and reduce variations or uncertainty in clinical practice.
Although we provided 11 key consensus statements, this CCS is insufficient for providing 
details on the rehabilitation approaches that health practitioners who are involved in 
treatment for patients with PD should use. The key statements provided in this study 
are not the same as the recommendations in a CPG. These should be viewed merely as 
expert opinions or suggestions. Some limitations of these CCS exist. One of the common 
disadvantages of the Delphi method is the lowering of the response rate per succeeding 
round, as we have also encountered. Additionally, the key questions selected in this CCS 
asked broad areas of the PD rehabilitation domain. Therefore, with reference to this CCS, 
the clinician should determine the evaluation and treatment options which best match the 
patient's current clinical status, interests, and needs.
In conclusion, the consensus panel has agreed on statements that address the needs 
of rehabilitation as a continuum in patients with PD. These statements include the 
rehabilitation initiation time, assessment items, rehabilitation contents, and complication 
management. This agreement can be used by physiatrists, rehabilitation therapists, and other 
practitioners who take care of patients with PD. The panel also highlighted the areas where 
a consensus could not be reached. Developing a more focused CCS or a CPG which targets 
specific rehabilitation approaches is considered the next step.
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